本页面由Tiger Trade Technology Pte. Ltd.提供服务

NEUROONE MEDICAL TECH

0.7512
-0.0288-3.69%
成交量:2.90万
成交额:2.20万
市值:3,808.06万
市盈率:-4.56
高:0.7894
开:0.7800
低:0.7383
收:0.7800
52周最高:1.16
52周最低:0.3954
股本:5,069.30万
流通股本:4,360.23万
量比:0.41
换手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-0.1648
每股收益(LYR):-0.0898
净资产收益率:-146.27%
总资产收益率:-63.40%
市净率:5.95
市盈率(LYR):-8.37

数据加载中...

公司资料

公司名字:
NEUROONE MEDICAL TECH
交易所:
NASDAQ
成立时间:
- -
员工人数:
18
公司地址:
7599 Anagram Drive,Eden Prairie,Minnesota,United States
邮编:
55344
电话:
传真:
- -
简介:
NeuroOne Medical Technologies Corporation根据特拉华州法律于2009年8月20日成立。该公司是一家医疗技术公司,专注于针对癫痫和帕金森病等大脑相关疾病的诊断、消融和深部脑刺激技术;用于全身疼痛管理的消融和刺激;以及包括诊断和刺激能力的药物递送。

董事

名称
职位
David Rosa
Chief Executive Officer and Director and President
Paul Buckman
Chairman and Director
Edward Andrle
Director
Jason Mills
Director
Jeffrey Mathiesen
Director

股东

名称
职位
David Rosa
Chief Executive Officer and Director and President
Christopher Volker
Chief Operating Officer
Ronald McClurg
Chief Financial Officer
Emily Johns
Chief Administrative Officer and General Counsel
Mark Christianson
Business Development Director, Medical Sales Liaison
Steve Mertens
Chief Technology Officer